"Editor’s note: This is part of a series of articles by The Defender responding to the latest media coverage of vaccines, triggered by the nomination of Robert F. Kennedy Jr. to lead the U.S. Department of Health and Human Services."
"... one of the country’s staunchest, most high-profile defenders of vaccine safety — known in some circles as the 'godfather of vaccines' — published a paper... that undermines the CDC and FDA 'safe and effective' narrative.
In an article published in July [2024] in the New England Journal of Medicine (NEJM), Dr. Stanley A. Plotkin, vaccinologist and emeritus professor of pediatrics at the University of Pennsylvania, and his co-authors identified gaps in vaccine safety testing, inadequacies in vaccine clinical trials and a lack of scientific knowledge about the biological mechanisms causing many common vaccine-related injuries.
The authors wrote:
'Postauthorization studies are needed to fully characterize the safety profile of a new vaccine, since prelicensure clinical trials have limited sample sizes, follow-up durations, and population heterogeneity'...
The NEJM article also noted that the biological mechanisms underlying common vaccine-related adverse events — including Guillain-Barré syndrome and myocarditis — are unknown and that for over three-quarters of vaccine-related health outcomes, there is not enough evidence to prove — or disprove — a causal link with vaccines...
NEJM cites ‘inadequate funding’ for vaccine safety research
The NEJM article suggested that a lack of federal funding for studying vaccine safety also has contributed to growing public skepticism toward vaccines...
Wayne Rohde, author of 'The Vaccine Court: The Dark Truth of America’s Vaccine Injury Compensation Program' and 'The Vaccine Court 2.0,' said more is needed than just additional funding. Rohde said the childhood vaccination schedule itself 'has never been studied in its entirety' for safety.
According to the Informed Consent Action Network (ICAN), 'None of the vaccine doses the CDC recommends for routine injection into children were licensed by the FDA based on a long-term placebo-controlled trial.' ...
Using VICP to fund vaccine injury research would benefit Big Pharma
... Rohde said there are growing calls for COVID-19 vaccine injuries to be covered under VICP [National Vaccine Injury Compensation Program], which would further strain the program’s finances.
'The current balance in the Vaccine Injury Trust fund will not be sufficient when COVID-19 vaccine injuries are permitted to be litigated in the VICP,' Rohde said. 'Money will be required not only for damage awards to petitioners, but also to handle the massive influx of petitions.'"
All content published on The Defender and Children’s Health Defense’s website is licensed under Creative Commons CC BY-NC-ND 4.0.